CNS Pharmaceuticals to Present at the H.C. Wainwright BioConnect Conference

HOUSTON, Jan. 7, 2022 /PRNewswire/ — CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that John…